1. Breuer K, Haussler S, Kapp A, Werfel T.

Staphylococcus aureus: colonizing features

and influence of an antibacterial treatment
in adults with atopic dermatitis. Br
J Dermatol. 2002; 147: 55-61.

18.-Cole GR, et al. Incidencia de infecciones intrahospitalarias en el Hospital San Rafael de Alajuela
durante el ao 2002. Revista Costarricense de Ciencias Mdicas. 2006; 21(3): 87-91


(10 Garcia Caballero, J Guia para la prevencin y controlde la infeccin en el
Hospital Universitario La Paz. Madrid, 2003)

CDC = Centers for Disease Control and Prevention [Centro de control y prevencin de
enfermedades]

IIH= INFE

4. Asensio Vegas A, Monge Jodra V, Soriano C, Lpez R, Gil A, Lizn Garca M:
Infeccin de la herida quirrgica: factores de riesgo y modelo predictivo. Med Clin
(Barc) 1993;100:521-525.


12.- Billstein S A. How the pharmaceutical industry brings an antibiotic drug to market in the
United States. Antimicrob Agents Chemother 1994; 38: 2679-82.
13. Moellering R C Jr. Past, present and future of antimicrobial agents. Am J Med 1995; 99(6A)
Suppl 1. Dec 29: S11-8.
6.- Acua G. Descubrimiento de la penicilina, un hito en la Medicina. Rev Mdica Clnica las
Condes.2002. Vol 13: 1.




1. Lazaro P. Enfermedades cutneas de origen bacteriano. En: Dermatologa
Pablo
Lzaro Ochaita. 3 Ed. Madrid: Ed. Meditcnica S.A. 2003:129-152
Dermatologa Peruana 2006; Vol 16(1)

3. Swartz MN, Weinberg AN. Consideraciones generales de las enfermedades
bacterianas. En: Fitzpatrick. Dermatologa en Medicina General. 5 Ed.
Buenos
Aires: Editorial Mdica Panamericana 2001:2297-2311.

6. Kloos WE, Schleifer KH. Isolation and characterization of staphylococci
from human skin. II. Descriptions of four new species: Staphylococcus
warneri, Staphylococcus capitis, Staphylococcus hominis, and Staphylococcus
simulans. Int J Syst Bacteriol; 1975: 25: 62-79.
7. Predari SC, Ligozzi M, Fontana R. Genotypic identification of methicillin-
resistant coagulase-negative staphylococci by polymerase chain reaction.
Antimicrob Agents Chemother 1991; 35: 2568-73.
8. Pulverer G, Pillich J. Pathogenic significance of coagulasenegative
staphylococci. In: Finland M, Marget W, Bartmann K, editors. Bacterial
infections: changes in their causative agents; trends and possible basis. New
York, Springer-Verlag, 1971, p. 91-6.



7. Yang J, Yu Y, Sun S, et al. Ceramide and other sphingolipid in cellular responses.
Cell Biochem Biophys. 2004;40:323-350.
8. Santamara V, Alvarado A. Flora cutnea como proteccin y barrera de la piel
normal. Rev Cent Dermatol Pascua. 2002;11:18-210.





5. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci.
Clin Microbiol Rev 1994; 7: 117-40.
10. Tan TY, Ng SY, Ng WX. Clinical significance of coagulase-negative staphylococci recovered from
nonsterile sites. J Clin Microbiol 2006; 44: 3413-4.

1.- Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources
and magnitude of bias. Epidemiol Infect 2009; 137(12): 1665-73. [ Links ]
2.- Conly J. Antimicrobial resistance in Canada. CMAJ 2002; 167:885-91. [ Links ]
3.- Colombo A L, Janini M, Salomao R, Medeiros E, Wey S B, Pignatari A C. Surveillance programs
for detection and characterization of emergent pathogens and antimicrobial resistance. Results
from the Division of Infectious Diseases, UNIFESP. An Acad Bras Cienc 2009;81 (3): 571-87. [ Links
]
4.- Borg M A, Cookson B D, Zarb 1 P, Scicluna E A. on behalf the ARM ed Steering Group and
Collaborators. Antibiotic resistance surveillance and control in the Mediterranean region: report of
the ARM ed Consensus Conference. J Infect Dev Ctries 2009; 3 (9): 654-9. [ Links ]
5.- Reynolds R. Antimicrobial resistance in the UK and Ireland. J Antimicrob Chemother 2000; 64
(I);119-123. [ Links ] Revista chilena de infectologa
versin impresa ISSN 0716-1018
Rev. chil. infectol. v.28 n.1 Santiago feb. 2011
doi: 10.4067/S0716-10182011000100004
Rev Chil Infect 2011; 28(1): 19-27

1. Barriga AG. La globalizacin de las enfermedades infecciosas. Rev. Med. IMSS 2003; 41 (5):
369-371
3. Jacobs M. Worldwide trends in antimicrobial resistance
among common respiratory tract pathogens in children.
Pediatr Infec is J. 2003; 22: suplemento (8) S109-S119
ENF INF MICROBIOL 2008 28 (3): 106-113